Free Trial

7 Growing Consumer Staples Stocks to Buy for Rising Inflation - 4 of 7

 
 

#4 - Kimberly-Clark (NYSE:KMB)

Sticking with household products that consumers use every day brings us to the next stock on this list, Kimberly-Clark Corporation (NYSE: KMB). In a year when the broader market is up approximately 17%, KMB stock has been an underperformer. However, a quick look at the fundamentals should give value-minded investors a reason to believe this is a consumer stock to buy if inflation is on the rise. 

In a similar theme to other stocks on this list, KMB stock trades at around 26x earnings, but its forward P/E is 19.9x, which is very attractive. The company is also expected to show 9% earnings growth in the next 12 months.  

The Kimberly-Clark analyst ratings on MarketBeat suggest that now may be a time to reduce your position. However, recent ratings hint at a price target that is significantly higher than the current price.  

And even if you're unsure about the direction of the stock, you'll be investing in another Dividend King with a 3.69% yield, a $4.72 annual payout, and has been increasing its payout for 52 years.  

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names. Read More 
Current Price
$131.32
Consensus Rating
Hold
Ratings Breakdown
6 Buy Ratings, 7 Hold Ratings, 2 Sell Ratings.
Consensus Price Target
$149.93 (14.2% Upside)

 

2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)

Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.

Click here to see Dan's full warning to the public.